Venzon Antunes M - Search Results

1

Evaluation of dried blood spots as an alternative matrix for therapeutic drug monitoring of abiraterone and delta(4)-abiraterone in prostate cancer patients.

Dillenburg Weiss TL, Gössling G, Venzon Antunes M, Schwartsmann G, Linden R, Gasparin Verza S. Dillenburg Weiss TL, et al. Among authors: venzon antunes m. J Pharm Biomed Anal. 2021 Feb 20;195:113861. doi: 10.1016/j.jpba.2020.113861. Epub 2020 Dec 26. J Pharm Biomed Anal. 2021. PMID: 33373824

2

Dried plasma spots for therapeutic monitoring of amikacin: Validation of an UHPLC-MS/MS assay and pharmacokinetic application.

da Silva ACC, de Lima Feltraco Lizot L, Bastiani MF, Venzon Antunes M, Brucker N, Linden R. da Silva ACC, et al. Among authors: venzon antunes m. J Pharm Biomed Anal. 2020 May 30;184:113201. doi: 10.1016/j.jpba.2020.113201. Epub 2020 Feb 24. J Pharm Biomed Anal. 2020. PMID: 32113122

3

Vancomycin and creatinine determination in dried blood spots: Analytical validation and clinical assessment.

Scribel L, Zavascki AP, Matos D, Silveira F, Peralta T, Gonçalves Landgraf N, Lamb Wink P, Cezimbra da Silva AC, Bordin Andriguetti N, Loss Lisboa L, Venzon Antunes M, Linden R. Scribel L, et al. Among authors: venzon antunes m. J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Jan 15;1137:121897. doi: 10.1016/j.jchromb.2019.121897. Epub 2019 Dec 10. J Chromatogr B Analyt Technol Biomed Life Sci. 2020. PMID: 31891859

4

Evaluation of the Tasso-SST® capillary blood microsampling device for the measurement of endogenous uracil levels.

Menestrina Dewes M, Cé da Silva L, Fazenda Meireles Y, Viana de Freitas M, Frank Bastiani M, Feltraco Lizot L, Zilles Hahn R, Venzon Antunes M, Linden R. Menestrina Dewes M, et al. Among authors: venzon antunes m. Clin Biochem. 2022 Sep;107:1-6. doi: 10.1016/j.clinbiochem.2022.06.003. Epub 2022 Jun 14. Clin Biochem. 2022. PMID: 35709975

5

Characterization of imatinib mesylate formulations distributed in South American countries: Determination of genotoxic impurities by UHPLC-MS/MS and dissolution profile.

Wolff FC, Dillenburg TL, Venzon Antunes M, Linden R, Comparsi Wagner S, Verza SG. Wolff FC, et al. Among authors: venzon antunes m. Biomed Chromatogr. 2018 Jul;32(7):e4222. doi: 10.1002/bmc.4222. Epub 2018 Apr 6. Biomed Chromatogr. 2018. PMID: 29488235

6

Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM Cohort.

Mc Laughlin AM, Helland T, Klima F, Koolen SLW, van Schaik RHN, Mathijssen RHJ, Neven P, Swen JJ, Guchelaar HJ, Dalenc F, White-Koning M, Michelet R, Mikus G, Schroth W, Mürdter T, Brauch H, Schwab M, Søiland H, Mellgren G, Thomas F, Kloft C, Hertz DL; CYP2D6 Endoxifen Percentage Activity Model (CEPAM) Consortium. Mc Laughlin AM, et al. Clin Pharmacol Ther. 2024 Mar 18. doi: 10.1002/cpt.3238. Online ahead of print. Clin Pharmacol Ther. 2024. PMID: 38494911

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6 results

Search Page